Kestra Medical Technologies (NASDAQ:KMTS) Now Covered by Analysts at Wolfe Research

Wolfe Research began coverage on shares of Kestra Medical Technologies (NASDAQ:KMTSFree Report) in a research report sent to investors on Monday, Marketbeat Ratings reports. The brokerage issued an outperform rating and a $29.00 price objective on the stock.

Other analysts have also issued research reports about the company. Stifel Nicolaus began coverage on Kestra Medical Technologies in a research note on Monday. They issued a “buy” rating and a $28.00 target price for the company. Piper Sandler began coverage on shares of Kestra Medical Technologies in a research note on Monday. They issued an “overweight” rating and a $27.00 price objective for the company. Wells Fargo & Company began coverage on shares of Kestra Medical Technologies in a research report on Monday. They issued an “overweight” rating and a $28.00 target price on the stock. Finally, The Goldman Sachs Group initiated coverage on shares of Kestra Medical Technologies in a research report on Monday. They set a “neutral” rating and a $24.00 price target for the company. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $27.67.

View Our Latest Research Report on Kestra Medical Technologies

Kestra Medical Technologies Price Performance

KMTS opened at $24.92 on Monday. Kestra Medical Technologies has a 12-month low of $20.00 and a 12-month high of $25.98.

Kestra Medical Technologies Company Profile

(Get Free Report)

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.

See Also

Analyst Recommendations for Kestra Medical Technologies (NASDAQ:KMTS)

Receive News & Ratings for Kestra Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kestra Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.